Skip to main content
. 2024 Mar 18;17:1721–1733. doi: 10.2147/JIR.S451538

Figure 2.

Figure 2

Expression of immunological molecules in healthy individuals and MMD patients. (AC) Differential expression of IgA, IgE and complement C3 in MMD patients with progressive-disease and stable-progressive. (DF) There is wide variation in changes in C3, C4 and IgE levels between patients with progressive disease and patients with stable disease. *P<0.05; **P<0.01; ***P<0.001.

Abbreviations: HC, indicates healthy control; ns, not significant.